Global Diagnosis of Autoimmune Diseases Market Size, Status and Forecast 2024-2031

Report ID: 922110 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Routine Laboratory Tests
        1.2.3 Inflammatory Markers
        1.2.4 Autoantibodies & Immunologic Test
        1.2.5 Other Tests
    1.3 Market by Application
        1.3.1 Global Diagnosis of Autoimmune Diseases Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Rheumatoid Arthritis
        1.3.3 Systemic Lupus Erythematosus
        1.3.4 Sjögren’s Syndrome
        1.3.5 Thyroiditis
        1.3.6 Scleroderma
        1.3.7 Other Diseases
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Diagnosis of Autoimmune Diseases Market Perspective (2016-2027)
    2.2 Diagnosis of Autoimmune Diseases Growth Trends by Regions
        2.2.1 Diagnosis of Autoimmune Diseases Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Diagnosis of Autoimmune Diseases Historic Market Share by Regions (2016-2021)
        2.2.3 Diagnosis of Autoimmune Diseases Forecasted Market Size by Regions (2022-2027)
    2.3 Diagnosis of Autoimmune Diseases Industry Dynamic
        2.3.1 Diagnosis of Autoimmune Diseases Market Trends
        2.3.2 Diagnosis of Autoimmune Diseases Market Drivers
        2.3.3 Diagnosis of Autoimmune Diseases Market Challenges
        2.3.4 Diagnosis of Autoimmune Diseases Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue
        3.1.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue (2016-2021)
        3.1.2 Global Diagnosis of Autoimmune Diseases Revenue Market Share by Players (2016-2021)
    3.2 Global Diagnosis of Autoimmune Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Diagnosis of Autoimmune Diseases Revenue
    3.4 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio
        3.4.1 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diagnosis of Autoimmune Diseases Revenue in 2020
    3.5 Diagnosis of Autoimmune Diseases Key Players Head office and Area Served
    3.6 Key Players Diagnosis of Autoimmune Diseases Product Solution and Service
    3.7 Date of Enter into Diagnosis of Autoimmune Diseases Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnosis of Autoimmune Diseases Breakdown Data by Type
    4.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Type (2016-2021)
    4.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2022-2027)

5 Diagnosis of Autoimmune Diseases Breakdown Data by Application
    5.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Application (2016-2021)
    5.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Diagnosis of Autoimmune Diseases Market Size (2016-2027)
    6.2 North America Diagnosis of Autoimmune Diseases Market Size by Type
        6.2.1 North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
        6.2.2 North America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
        6.2.3 North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
    6.3 North America Diagnosis of Autoimmune Diseases Market Size by Application
        6.3.1 North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
        6.3.2 North America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
        6.3.3 North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
    6.4 North America Diagnosis of Autoimmune Diseases Market Size by Country
        6.4.1 North America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
        6.4.2 North America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Diagnosis of Autoimmune Diseases Market Size (2016-2027)
    7.2 Europe Diagnosis of Autoimmune Diseases Market Size by Type
        7.2.1 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
        7.2.2 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
        7.2.3 Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
    7.3 Europe Diagnosis of Autoimmune Diseases Market Size by Application
        7.3.1 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
        7.3.2 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
        7.3.3 Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
    7.4 Europe Diagnosis of Autoimmune Diseases Market Size by Country
        7.4.1 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
        7.4.2 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size (2016-2027)
    8.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type
        8.2.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
    8.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application
        8.3.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
    8.4 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region
        8.4.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Diagnosis of Autoimmune Diseases Market Size (2016-2027)
    9.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Type
        9.2.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
        9.2.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
        9.2.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
    9.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Application
        9.3.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
        9.3.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
        9.3.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
    9.4 Latin America Diagnosis of Autoimmune Diseases Market Size by Country
        9.4.1 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
        9.4.2 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size (2016-2027)
    10.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type
        10.2.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2027)
    10.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application
        10.3.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2027)
    10.4 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country
        10.4.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Details
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Introduction
        11.1.4 Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Siemens
        11.2.1 Siemens Company Details
        11.2.2 Siemens Business Overview
        11.2.3 Siemens Diagnosis of Autoimmune Diseases Introduction
        11.2.4 Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.2.5 Siemens Recent Development
    11.3 Inova Diagnostics
        11.3.1 Inova Diagnostics Company Details
        11.3.2 Inova Diagnostics Business Overview
        11.3.3 Inova Diagnostics Diagnosis of Autoimmune Diseases Introduction
        11.3.4 Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.3.5 Inova Diagnostics Recent Development
    11.4 GRIFOLS
        11.4.1 GRIFOLS Company Details
        11.4.2 GRIFOLS Business Overview
        11.4.3 GRIFOLS Diagnosis of Autoimmune Diseases Introduction
        11.4.4 GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.4.5 GRIFOLS Recent Development
    11.5 Danaher
        11.5.1 Danaher Company Details
        11.5.2 Danaher Business Overview
        11.5.3 Danaher Diagnosis of Autoimmune Diseases Introduction
        11.5.4 Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.5.5 Danaher Recent Development
    11.6 Bio-Rad Laboratories
        11.6.1 Bio-Rad Laboratories Company Details
        11.6.2 Bio-Rad Laboratories Business Overview
        11.6.3 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Introduction
        11.6.4 Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.6.5 Bio-Rad Laboratories Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Details
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Diagnosis of Autoimmune Diseases Introduction
        11.7.4 Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.7.5 Abbott Recent Development
    11.8 Trinity Biotech
        11.8.1 Trinity Biotech Company Details
        11.8.2 Trinity Biotech Business Overview
        11.8.3 Trinity Biotech Diagnosis of Autoimmune Diseases Introduction
        11.8.4 Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.8.5 Trinity Biotech Recent Development
    11.9 Werfen
        11.9.1 Werfen Company Details
        11.9.2 Werfen Business Overview
        11.9.3 Werfen Diagnosis of Autoimmune Diseases Introduction
        11.9.4 Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.9.5 Werfen Recent Development
    11.10 Protagen
        11.10.1 Protagen Company Details
        11.10.2 Protagen Business Overview
        11.10.3 Protagen Diagnosis of Autoimmune Diseases Introduction
        11.10.4 Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.10.5 Protagen Recent Development
    11.11 HYCOR Biomedical
        11.11.1 HYCOR Biomedical Company Details
        11.11.2 HYCOR Biomedical Business Overview
        11.11.3 HYCOR Biomedical Diagnosis of Autoimmune Diseases Introduction
        11.11.4 HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.11.5 HYCOR Biomedical Recent Development
    11.12 HTG Molecular Diagnostics
        11.12.1 HTG Molecular Diagnostics Company Details
        11.12.2 HTG Molecular Diagnostics Business Overview
        11.12.3 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Introduction
        11.12.4 HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.12.5 HTG Molecular Diagnostics Recent Development
    11.13 EUROIMMUN AG
        11.13.1 EUROIMMUN AG Company Details
        11.13.2 EUROIMMUN AG Business Overview
        11.13.3 EUROIMMUN AG Diagnosis of Autoimmune Diseases Introduction
        11.13.4 EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021)
        11.13.5 EUROIMMUN AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Routine Laboratory Tests
    Table 3. Key Players of Inflammatory Markers
    Table 4. Key Players of Autoantibodies & Immunologic Test
    Table 5. Key Players of Other Tests
    Table 6. Global Diagnosis of Autoimmune Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Diagnosis of Autoimmune Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Diagnosis of Autoimmune Diseases Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2016-2021)
    Table 10. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2022-2027)
    Table 12. Diagnosis of Autoimmune Diseases Market Trends
    Table 13. Diagnosis of Autoimmune Diseases Market Drivers
    Table 14. Diagnosis of Autoimmune Diseases Market Challenges
    Table 15. Diagnosis of Autoimmune Diseases Market Restraints
    Table 16. Global Diagnosis of Autoimmune Diseases Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Diagnosis of Autoimmune Diseases Market Share by Players (2016-2021)
    Table 18. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2020)
    Table 19. Ranking of Global Top Diagnosis of Autoimmune Diseases Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Diagnosis of Autoimmune Diseases Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Diagnosis of Autoimmune Diseases Product Solution and Service
    Table 23. Date of Enter into Diagnosis of Autoimmune Diseases Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2016-2021)
    Table 27. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Diagnosis of Autoimmune Diseases Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2016-2021)
    Table 31. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Thermo Fisher Scientific Company Details
    Table 64. Thermo Fisher Scientific Business Overview
    Table 65. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Product
    Table 66. Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 67. Thermo Fisher Scientific Recent Development
    Table 68. Siemens Company Details
    Table 69. Siemens Business Overview
    Table 70. Siemens Diagnosis of Autoimmune Diseases Product
    Table 71. Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 72. Siemens Recent Development
    Table 73. Inova Diagnostics Company Details
    Table 74. Inova Diagnostics Business Overview
    Table 75. Inova Diagnostics Diagnosis of Autoimmune Diseases Product
    Table 76. Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 77. Inova Diagnostics Recent Development
    Table 78. GRIFOLS Company Details
    Table 79. GRIFOLS Business Overview
    Table 80. GRIFOLS Diagnosis of Autoimmune Diseases Product
    Table 81. GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 82. GRIFOLS Recent Development
    Table 83. Danaher Company Details
    Table 84. Danaher Business Overview
    Table 85. Danaher Diagnosis of Autoimmune Diseases Product
    Table 86. Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 87. Danaher Recent Development
    Table 88. Bio-Rad Laboratories Company Details
    Table 89. Bio-Rad Laboratories Business Overview
    Table 90. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Product
    Table 91. Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 92. Bio-Rad Laboratories Recent Development
    Table 93. Abbott Company Details
    Table 94. Abbott Business Overview
    Table 95. Abbott Diagnosis of Autoimmune Diseases Product
    Table 96. Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 97. Abbott Recent Development
    Table 98. Trinity Biotech Company Details
    Table 99. Trinity Biotech Business Overview
    Table 100. Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 101. Trinity Biotech Recent Development
    Table 102. Werfen Company Details
    Table 103. Werfen Business Overview
    Table 104. Werfen Diagnosis of Autoimmune Diseases Product
    Table 105. Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 106. Werfen Recent Development
    Table 107. Protagen Company Details
    Table 108. Protagen Business Overview
    Table 109. Protagen Diagnosis of Autoimmune Diseases Product
    Table 110. Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 111. Protagen Recent Development
    Table 112. HYCOR Biomedical Company Details
    Table 113. HYCOR Biomedical Business Overview
    Table 114. HYCOR Biomedical Diagnosis of Autoimmune Diseases Product
    Table 115. HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 116. HYCOR Biomedical Recent Development
    Table 117. HTG Molecular Diagnostics Company Details
    Table 118. HTG Molecular Diagnostics Business Overview
    Table 119. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Product
    Table 120. HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 121. HTG Molecular Diagnostics Recent Development
    Table 122. EUROIMMUN AG Company Details
    Table 123. EUROIMMUN AG Business Overview
    Table 124. EUROIMMUN AG Diagnosis of Autoimmune Diseases Product
    Table 125. EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2016-2021) & (US$ Million)
    Table 126. EUROIMMUN AG Recent Development
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diagnosis of Autoimmune Diseases Market Share by Type: 2020 VS 2027
    Figure 2. Routine Laboratory Tests Features
    Figure 3. Inflammatory Markers Features
    Figure 4. Autoantibodies & Immunologic Test Features
    Figure 5. Other Tests Features
    Figure 6. Global Diagnosis of Autoimmune Diseases Market Share by Application: 2020 VS 2027
    Figure 7. Rheumatoid Arthritis Case Studies
    Figure 8. Systemic Lupus Erythematosus Case Studies
    Figure 9. Sjögren’s Syndrome Case Studies
    Figure 10. Thyroiditis Case Studies
    Figure 11. Scleroderma Case Studies
    Figure 12. Other Diseases Case Studies
    Figure 13. Diagnosis of Autoimmune Diseases Report Years Considered
    Figure 14. Global Diagnosis of Autoimmune Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Diagnosis of Autoimmune Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Diagnosis of Autoimmune Diseases Market Share by Regions: 2020 VS 2027
    Figure 17. Global Diagnosis of Autoimmune Diseases Market Share by Regions (2022-2027)
    Figure 18. Global Diagnosis of Autoimmune Diseases Market Share by Players in 2020
    Figure 19. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Diagnosis of Autoimmune Diseases Revenue in 2020
    Figure 21. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2016-2021)
    Figure 22. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2022-2027)
    Figure 23. North America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
    Figure 25. North America Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
    Figure 26. North America Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
    Figure 27. United States Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
    Figure 31. Europe Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
    Figure 32. Europe Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
    Figure 33. Germany Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Region (2016-2027)
    Figure 43. China Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
    Figure 51. Latin America Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
    Figure 52. Latin America Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
    Figure 53. Mexico Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Country (2016-2027)
    Figure 59. Turkey Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Diagnosis of Autoimmune Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 63. Siemens Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 64. Inova Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 65. GRIFOLS Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 66. Danaher Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 68. Abbott Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 69. Trinity Biotech Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 70. Werfen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 71. Protagen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 72. HYCOR Biomedical Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 73. HTG Molecular Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 74. EUROIMMUN AG Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher Scientific
Siemens
Inova Diagnostics
GRIFOLS
Danaher
Bio-Rad Laboratories
Abbott
Trinity Biotech
Werfen
Protagen
HYCOR Biomedical
HTG Molecular Diagnostics
EUROIMMUN AG
Frequently Asked Questions
Diagnosis of Autoimmune Diseases report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Diagnosis of Autoimmune Diseases report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Diagnosis of Autoimmune Diseases report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

COVID-19 Medicine

In 2021, the global COVID-19 Medicine market size will be US$ XX million and it is expected to re ... Read More